These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8267915)

  • 21. Identification and characterization of linear neutralizing domains in the HIV-2 glycoproteins.
    Ewa B; Chiodi F; Norrby E
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1393. PubMed ID: 1466964
    [No Abstract]   [Full Text] [Related]  

  • 22. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA
    Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins.
    Marcelino JM; Barroso H; Gonçalves F; Silva SM; Novo C; Gomes P; Camacho R; Taveira N
    J Clin Microbiol; 2006 Feb; 44(2):607-11. PubMed ID: 16455923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection.
    Manca F; De Berardinis P; Fenoglio D; Ombra MN; Li Pira G; Saverino D; Autiero M; Lozzi L; Bracci L; Guardiola J
    Eur J Immunol; 1996 Oct; 26(10):2461-9. PubMed ID: 8898961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of T-lymphocytes for adoptive immunotherapy by lymphapheresis of HIV-infected patients without alterations of virological, immunological or clinical parameters.
    van Lunzen J; Schmitz J; Dengler K; Schmidt L; Schmitz H; Dietrich M
    Br J Haematol; 1994 Sep; 88(1):46-51. PubMed ID: 7803255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological reactivities of Ghanaian sera with HIV-1, HIV-2, and simian immunodeficiency virus SIVagm.
    Kawamura M; Ishikawa K; Mingle JA; Osei-Kwasi M; Afoakwa SN; Nettey VB; Chosa T; Hayami M
    AIDS; 1989 Sep; 3(9):609-11. PubMed ID: 2551342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120.
    Höhn H; Kortsik C; Tully G; Nilges K; Necker A; Freitag K; Neukirch C; Galle P; Löhr H; Maeurer MJ
    Eur J Immunol; 2003 Jun; 33(6):1613-23. PubMed ID: 12778479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.
    Beretta A; Weiss SH; Rappocciolo G; Mayur R; De Santis C; Quirinale J; Cosma A; Robbioni P; Shearer GM; Berzofsky JA
    J Infect Dis; 1996 Feb; 173(2):472-6. PubMed ID: 8568315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of subjects with an indeterminate HIV-2 western blot.
    Pepin J; Dalby M; Gaye I; Berry N; Whittle H
    AIDS; 1991 Oct; 5(10):1274-5. PubMed ID: 1786162
    [No Abstract]   [Full Text] [Related]  

  • 31. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A; Tanaka-Taya K; Ueda S
    Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2.
    Carpio E; Duarte C; Hinkula J; Broliden PA; Rosén J; Campal A; Gavilondo J; Wahren B; Jondal M
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):97-101. PubMed ID: 1707645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections.
    Vanham G; Kestens L; Gigase P; Colebunders R; Vandenbruaene M; Brijs L; Ceuppens JL
    Clin Exp Immunol; 1990 Oct; 82(1):3-9. PubMed ID: 2208794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses.
    Fiorentini S; Marconi P; Avolio M; Marini E; Garrafa E; Caracciolo S; Rossi D; Bozac A; Becker PD; Gentili F; Facchetti F; Guzman CA; Manservigi R; Caruso A
    Microbes Infect; 2007 Jul; 9(8):988-96. PubMed ID: 17553721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular immune factors associated with mother-to-infant transmission of HIV.
    Clerici M; Sison AV; Berzofsky JA; Rakusan TA; Brandt CD; Ellaurie M; Villa M; Colie C; Venzon DJ; Sever JL
    AIDS; 1993 Nov; 7(11):1427-33. PubMed ID: 8280407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amplification of T-cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome.
    Dis Markers; 1990; 8(4):223-4. PubMed ID: 2150930
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant peptides derived from the env-gene of HIV-2 in the serodiagnosis of HIV-2 infections.
    Schulz TF; Oberhuber W; Hofbauer JM; Hengster P; Larcher C; Gürtler LC; Tedder R; Wachter H; Dierich MP
    AIDS; 1989 Mar; 3(3):165-72. PubMed ID: 2496732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The isolation and characteristics of monoclonal antibodies to recombinant proteins of HIV-1 and HIV-2--the env and gag gene products].
    Pugach AV; Zverev VV; Pille ER; Shukhmina NR; Mel'nikova NL; Nosik DN; Maliushova VV; Andzhaparidze OG
    Vopr Virusol; 1993; 38(6):253-5. PubMed ID: 8303883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of spinal fluid beta 2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1.
    Lucey DR; McGuire SA; Clerici M; Hall K; Benton J; Butzin CA; Ward WW; Shearer G; Boswell RN; Hendrix CW
    J Infect Dis; 1991 May; 163(5):971-5. PubMed ID: 1673466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.